Reyataz (atazanavir sulfate) is a small molecule pharmaceutical. Atazanavir sulfate was first approved as Reyataz on 2004-03-01. It is used to treat acquired immunodeficiency syndrome in the USA. It has been approved in Europe to treat HIV infections.
|Common Name||Atazanavir sulfate|
|Indication||acquired immunodeficiency syndrome, hiv infections|
|Drug Class||Antivirals: HIV protease inhibitors (saquinavir type)|